Latest Interviews

Which jobs put you in the best position for the future? (part 3) @ Cambridge University

Career strategist advises early professionals to accumulate transferable skills and financial runway by prioritizing high-performance corporate sectors over nonprofit roles or rigid academic paths. The framework defines flexible career capital through five specific assets: transferable skills, influential networks, credentials, demonstrated character, and a 12-to-24-month financial safety net. By combining intensive upskilling methods like coding bootcamps with foundational mental health practices and targeted graduate study in applied sciences, individuals can secure adaptable trajectories capable of withstanding future industry shifts.

How to find the right career for you? (part 4) @ Cambridge University

This framework challenges the efficacy of introspection and standard career tests, arguing that predictive validity is highest only when candidates directly simulate actual work through investigation and trial. By adopting a five-step exploration process that treats career choices as iterative hypotheses, individuals like Tony Blair and Jess avoid narrow framing to accumulate "career capital" across distinct phases of exploration, building, and impact. The strategy ultimately prioritizes short-term, diverse experimentation to identify genuine fit before making long-term commitments, ensuring that future decisions remain adaptable to shifting personal preferences and industry realities.

Can one person make a difference? (part 2a) @ Cambridge University

The presentation analyzes high-impact career strategies by contrasting the marginal utility of wealth with traditional medical practice, highlighting historical cases where accelerating scientific discoveries by mere years could have saved millions of lives. It proposes an "easy baseline" approach where individuals pursue personally satisfying careers while donating ten percent of their income to effective charities like GiveDirectly, leveraging the vast disparity between the global wealthy minority and the rest. This strategy, championed by the "Giving What We Can" movement, aims to maximize aggregate well-being by utilizing the multiplicative value of transfers rather than demanding personal sacrifice in career choice.

Revolutionizing Cancer Treatment with Immunotherapy: Talks at GS Session Highlights

Giovanni Caforio, Laurie Glimcher, Jill O'Donnell-Tormey, Dr. Giovanni Coforio, Dr. Lori Glimcher, Jamie

Immunotherapy has emerged as a transformative cancer treatment by harnessing the patient's immune system to target mutated cells through checkpoint blockade, offering a personalized alternative to the non-specific toxicity of traditional chemotherapy. Clinical trials in melanoma and lung cancer have demonstrated that this approach yields response rates exceeding 60% and has nearly eliminated the need for first-line chemotherapy in these malignancies. Looking ahead, the field aims to expand these outcomes by addressing patient non-responsiveness through strategies that personalize therapy based on unique tumor genetic profiles.

Why OCaml

Approximately a decade ago, Jane Street adopted OCaml as its primary functional programming language to secure C-like performance and rigorous type safety while maintaining development conciseness. This strategic choice serves as a filtering mechanism for hiring, attracting highly motivated engineers through a specialized one-month training program that results in a consolidated, high-performing workforce. Although the firm faces ecosystem limitations compared to mainstream languages, the implementation of a single language across its multi-billion-dollar systems enables significant code reuse and shifts the priority from empirical testing to the universal guarantees of static type checking.

Effective ML 2011 Harvard CS51 Part 1

Ron Minsky

Ron Minsky, a technical leader at Jane Street Capital, presented a comprehensive case for prioritizing code correctness and maintainability through strict OCaml design principles that leverage the type system to enforce data invariants and ensure pattern match exhaustiveness. The lecture outlined specific architectural strategies, including mandatory interfaces, uniform naming conventions, and a "reader-over-writer" philosophy, which collectively minimize cognitive load and prevent silent failures in high-stakes financial systems. Additionally, the speaker addressed immediate course logistics by extending the Moogle project description deadline and recommending simple list-based implementations to avoid unnecessary debugging complexity.

Caml Trading

Carl Curry, Ron Minsky

Jane Street Capital, a proprietary trading firm operating in four global cities, transitioned its primary development stack to the functional programming language OCaml to satisfy critical demands for absolute correctness, high performance, and code maintainability. This adoption enables the firm's 35 core developers to leverage OCaml's powerful type system and algebraic data types for static exhaustiveness checks, ensuring the rigorous standards required to process billions of dollars in daily equity trades without error. While the language presents challenges in ecosystem maturity, the firm has actively mitigated these gaps through its Jane Street Summer Project and achieved superior hiring outcomes by attracting engineers skilled in functional paradigms.

Seven Implementations of Incremental

Incremental is an internal OCaml library that efficiently refreshes large computations by modeling logic as a dependency graph, allowing localized updates when only small data subsets change. Through eight iterative development phases, the team resolved critical academic limitations regarding garbage collection and dynamic graph restructuring, culminating in a production-ready V8 implementation that achieved a threefold speedup using generalized algebraic data types. This technology successfully transformed a slow trading system frontend into the suite's fastest application and is now being explored for reactive JavaScript compilation and efficient functional data structure diffing.

Mrs. Laura Bush - A Conversation on Empowering Women in Afghanistan: Talks at GS Session Highlights

Laura Bush, Mrs. Laura Bush, Manizha Naderi, Mrs. Bush, Manisha

Former First Lady Laura Bush launched her book *We Are Afghan Women*, which chronicles the struggles and resilience of 29 Afghan women alongside activist Manisha, who details the founding of a shelter network now serving over 21,000 survivors. The work highlights how marginalized women like Manisha transformed decades of conflict into progress, establishing educational systems and advocacy groups while noting that the nation's reconstruction may take another forty years. Bush emphasizes that female civic participation is a prerequisite for national stability, drawing parallels to the 1920 U.S. suffrage movement to advocate for patient, long-term investment in Afghan women's rights.

Mike Milken │ Public Health and Prosperity

Mike Milken

Historical shifts in medical research funding and technological advancements have reduced genome sequencing costs to approximately $1,000 while driving significant economic growth through improved public health. A modern summit now unites government agencies, pharmaceutical entities, and insurers to address the trillion-dollar burden of lifestyle-related diseases by prioritizing prevention, accelerating translational science, and fostering public-private partnerships. This collective strategy aims to fundamentally transform the treatment of life-threatening conditions through innovations like cancer vaccines and immunology drugs within the next few years.

Carrots, Sticks and Nudges: Balancing Public Health and Personal Freedom

Megan McArdle, David Boaz, Bob Casey, Doug Teitelbaum

A bipartisan panel led by Senators Casey and Burr convened to address critical gaps in pandemic preparedness, stagnant antibiotic innovation, and the evolving definition of public health beyond infectious diseases. Experts highlighted systemic failures ranging from the erosion of scientific trust and bureaucratic barriers to bariatric surgery to the market disincentives preventing new antibiotic development and the regulatory controversies surrounding e-cigarettes. Ultimately, the discussion emphasized that future progress requires a "multiplier effect" of collaboration between government and private sectors, coupled with greater empathy for individuals struggling with chronic conditions to bridge the divide between public health policy and patient reality.

Public Health, Medical Research and the Cancer Moonshot: A Collaboration to Change the World

Michael Milken, Francis Collins, Linda Fried, Robert Hugin, Freda Lewis-Hall

Vice President Biden and medical leaders are launching a strategic "Cancer Moonshot" to overcome siloed research through a $680 million federal investment and the Precision Medicine Initiative's enrollment of one million Americans. The framework prioritizes seven key themes, including early detection blood tests, single-cell analysis, and public-private partnerships modeled after the Accelerating Medicines Partnership, while explicitly warning against overpromising a timeline for a universal cure. Parallel to the National Institutes of Health and FDA funding, the initiative integrates public health science to address prevention drivers and leverages global data collaboration to accelerate the shift toward data-driven, individualized cancer therapies.

Public Health Summit Dinner March 2, 2016

Mike Milken, Tom Frieden, Rob Califf, Fred Upton, Nancy Pelosi, Francis Collins

This event featured key figures including Francis Collins, FDA Commissioner Rob Califf, and CDC Director Tom Frieden discussing critical public health challenges such as the implementation gap between knowledge and action, rising opioid overdose deaths, and the threat of a post-antibiotic era. The proceedings highlighted specific policy responses ranging from Mexico's successful food taxes and "health stops" to the U.S. House passing the 21st Century Cures Act and funding the Brain Initiative, alongside clinical breakthroughs in treating depression and heart failure. To address these systemic issues, officials urged for robust funding, the adoption of global "find, stop, prevent" strategies, and a massive volunteer effort for the Precision Medicine Initiative to accelerate biomedical discovery.

The Promise of Public Health

Mike Klowden, Richard Besser, Nancy Brown, Thomas Farley, Joseph Jimenez, Fred Upton

The Milken Institute's inaugural Public Health Summit convened key industry and government leaders, including Novartis CEO Joe Jimenez, CDC Director Tom Frieden, and Congressman Fred Upton, to advocate for elevating disease prevention alongside medical cures. Participants analyzed critical strategies such as conditional reimbursement models, real-time data utilization, and the "21st Century Cures Act" to address looming challenges posed by an aging global population and stagnant biotech venture capital. The consensus emphasized that sustainable health outcomes require shifting from volume-based treatment to outcome-based policies that integrate genomics, behavioral interventions, and bipartisan legislative support to bridge significant disparities in US public health metrics.

Atul Butte | Driving Public Health: A Trillion Points of Data

Atul Butte

Addressing the exponential growth of biomedical data, the presentation details UCSF's initiative to consolidate electronic records from 14.1 million patients into a unified warehouse that shifts disease tracking from code-based to molecular-based systems. This infrastructure enables low-cost computational predictions, such as the rapid repurposing of imipramine for lung cancer, which accelerated a clinical trial from concept to authorization within fifteen months. By creating dynamic maps of patient disease progression, the project aims to redefine accountable care through continuous, population-level monitoring rather than isolated clinical encounters.